The mission of Tulane’s Office of Technology Transfer & Intellectual Property Development is to. . .
The Office of Technology Transfer and Intellectual Property Development is fully functional and operating at normal capacity.
We expect this to continue even if the university further suspends on-site operations for purposes of decreasing COVID-19 transmission.
As Tulane University makes decisions on how to respond to the COVID-19 pandemic, we want to reassure the university community that our primary concern is the safety of our research participants and the research team members at the university. Our secondary goal is to preserve the scientific integrity of the research and its protocols.
Required changes to research practice based on the coronavirus will be posted on the Office of Research website, https://research.tulane.edu/. Please check the website frequently if you are interacting with research participants.
Tulane University COVID-19 website (information, FAQs, and current recommendations): https://campushealth.tulane.edu/health-center/primary-care/infectious-disease-care/coronavirus-covid-19.
Tulane University President’s announcements on university actions as to COVID-19: https://tulane.edu/tulane-university-moves-online-instruction-cancels-large-events.
Additional guidelines issued by the Tulane School of Medicine are available at https://medicine.tulane.edu/research-covid-19-information.
Recommendations from the Centers for Disease Control (CDC): https://www.cdc.gov/coronavirus/2019-nCoV/index.html.